| __timestamp | Corcept Therapeutics Incorporated | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 26551000 | 91813000 |
| Thursday, January 1, 2015 | 50286000 | 178203000 |
| Friday, January 1, 2016 | 81321000 | 216080000 |
| Sunday, January 1, 2017 | 159201000 | 241203000 |
| Monday, January 1, 2018 | 251247000 | 214109000 |
| Tuesday, January 1, 2019 | 306486000 | 204890000 |
| Wednesday, January 1, 2020 | 353874000 | 227976000 |
| Friday, January 1, 2021 | 365978000 | 356128000 |
| Saturday, January 1, 2022 | 401858000 | 426409000 |
| Sunday, January 1, 2023 | 482375000 | 837999000 |
In pursuit of knowledge
In the dynamic world of biotechnology, Corcept Therapeutics Incorporated and HUTCHMED (China) Limited have showcased remarkable revenue trajectories over the past decade. From 2014 to 2023, Corcept Therapeutics saw its revenue skyrocket by over 1,700%, starting from a modest $26.6 million to an impressive $482.4 million. Meanwhile, HUTCHMED (China) Limited experienced a substantial growth of over 800%, with revenues climbing from $91.8 million to $838 million.
This period highlights the resilience and strategic prowess of these companies in navigating the competitive biotech landscape. Notably, HUTCHMED's revenue leap in 2023, nearly doubling from the previous year, underscores its aggressive market expansion and innovation. As these companies continue to evolve, their financial performance offers valuable insights into the broader trends shaping the biotech industry.
Revenue Insights: Eli Lilly and Company and HUTCHMED (China) Limited Performance Compared
Who Generates More Revenue? Amgen Inc. or Corcept Therapeutics Incorporated
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Corcept Therapeutics Incorporated
Revenue Showdown: Genmab A/S vs Corcept Therapeutics Incorporated
Annual Revenue Comparison: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
Breaking Down Revenue Trends: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Annual Revenue Comparison: Pharming Group N.V. vs HUTCHMED (China) Limited
Revenue Insights: Corcept Therapeutics Incorporated and Cytokinetics, Incorporated Performance Compared
Corcept Therapeutics Incorporated vs MorphoSys AG: Examining Key Revenue Metrics
Annual Revenue Comparison: Corcept Therapeutics Incorporated vs Vericel Corporation
Vericel Corporation or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?
Who Generates More Revenue? HUTCHMED (China) Limited or Travere Therapeutics, Inc.